IL-6 Cytokine Useful for Monitoring of Severe Epidermolysis Bullosa
Targeted anti-inflammatory treatment may be reasonable for addressing the causes ofsystemic inflammation in those with severe junctional and dystrophic epidermolysis bullosa.
Related Articles
Canalys Research: Global Smartphone Market Rebounds 7% in 2024, Reaching 1.22B Units
According to the latest Canalys research, the global smartphone market grew 7% in 2024, reaching 1.22 billion units, marking a rebound following two consecutive years…
The future of Apple Vision Pro is in medicine
One year after its release, the headset is springing up in operating rooms and doctors’ offices.
How time zones impact your work and mental health
For better productivity and wellness, nearshore roles to a similar time zone.
WHO Executive Board, 156th session
The 156th session of the WHO Executive Board take place on 3–11 February 2025.
World’s longest: 450-feet cargo sail ship with 5,842 tons cargo capacity launched
This ship is designed to produce up to 80 percent less greenhouse gas emissions.
OTC hearing aid eyeglasses available soon in US following FDA approval
Nuance Audio showcased its glasses with built-in hearing aids at CES 2025. Now that the product is FDA-approved, it will be available in the US…
How Thomson Reuters and Anthropic built an AI that tax professionals actually trust
Thomson Reuters is bringing AI to tax professionals in a big way. The company has partnered with Anthropic to use its Claude AI technology in…
Anthropic claims new AI security method blocks 95% of jailbreaks, invites red teamers to try
Two years after ChatGPT hit the scene, there are numerous large language models (LLMs), and nearly all remain ripe for jailbreaks — specific prompts and…
Don’t Drink the Water: Italy’s Learnings From PFAS Disaster
PFAS exposure in Europe has been linked to excess deaths and health risks, prompting biomonitoring efforts and policy action to regulate these persistent chemicals.
Uganda starts clinical trial of vaccine for Sudan strain of Ebola
Uganda has begun a trial vaccination programme for the strain of Ebola viral infection that is behind Sudan’s latest outbreak, according to the World Health…
